CD40: Novel association with crohn's disease and replication in multiple sclerosis susceptibility

PLoS ONE

Volumn 5, Issue 7, 2010, Pages 1-4

  Blanco Kelly, Fiona ^a   Matesanz, Fuencisla ^b,i   Alcina, Antonio ^b,i   Teruel, María ^b   Díaz Gallo, Lina M ^b   Gómez García, María ^c   López Nevot, Miguel A ^c   Rodrigo, Luis ^d   Nieto, Antonio ^e   Cardeña, Carlos ^f   Alcain, Guillermo ^g   Díaz Rubio, Manuel ^a   de la Concha, Emilio G ^a,i   Fernandez, Oscar ^h,i   Arroyo, Rafael ^a,i   Martín, Javier ^b   Urcelay, Elena ^a,i  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^f HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^h HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

ⁱ Members of the Red Española de Esclerosis Mú ltiple REEM   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; SPAIN; ULCERATIVE COLITIS; ALLELE; GENETIC PREDISPOSITION; GENETICS;

ADULT; ALLELES; ANTIGENS, CD40; COLITIS, ULCERATIVE; CROHN DISEASE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 77955384911     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011520     Document Type: Article

References (32)

1. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, et al. (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system. In Immunol Rev. pp 152-72.
2. Tomer Y, Concepcion E, Greenberg DA (2002) A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12: 1129-35.
3. Ban Y, Tozaki T, Taniyama M, Tomita M (2006) Association of a C/T singlenucleotide polymorphism in the 59 untranslated region of the CD40 gene with Graves' disease in Japanese. Thyroid 16: 443-6.
4. Kurylowicz A, Kula D, Ploski R, Skorka A, Jurecka-Lubieniecka B, et al. (2005) Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease. Thyroid 15: 1119-24.
5. Kozak M (1987) At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 196: 947-50.
6. Jacobson EM, Concepcion E, Oashi T, Tomer Y (2005) A Graves' diseaseassociated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146: 2684-91. Epub 2005 Feb 24.
7. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, et al. (2008) Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 40: 1216-23. Epub 2008 Sep 14.
8. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, et al. (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328-30.
9. Chen CR, Aliesky HA, Guo J, Rapoport B, McLachlan SM (2006) Blockade of costimulation between T cells and antigen-presenting cells: an approach to suppress murine Graves' disease induced using thyrotropin receptor-expressing adenovirus. Thyroid 16: 427-34.
10. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, et al. (1996) CD40- CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 93: 2499-504.
11. Mohan C, Shi Y, Laman JD, Datta SK (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154: 1470-80.
12. Balasa B, Krahl T, Patstone G, Lee J, Tisch R, et al. (1997) CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 159: 4620-7.
13. Chadha S, Miller K, Farwell L, Sacks S, Daly MJ, et al. (2006) Haplotype analysis of tumour necrosis factor receptor genes in 1p36: no evidence for association with systemic lupus erythematosus. Eur J Hum Genet 14: 69- 78.
14. Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, et al. (2007) The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med Genet 8: 71.
15. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41: 824-8. Epub 2009 Jun 14.
16. Gao D, Wagner AH, Fankhaenel S, Stojanovic T, Schweyer S, et al. (2005) CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis. Gut 54: 70-7.
17. Battaglia E, Biancone L, Resegotti A, Emanuelli G, Fronda GR, et al. (1999) Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease. Am J Gastroenterol 94: 3279-84.
18. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-31.
19. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 170: 2-6; discussion 16-9.
20. Peters AL, Stunz LL, Bishop GA (2009) CD40 and autoimmunity: The dark side of a great activator. Semin Immunol 10: 10.
21. Iezzi G, Sonderegger I, Ampenberger F, Schmitz N, Marsland BJ, et al. (2009) CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc Natl Acad Sci U S A 106: 876-81. Epub 2009 Jan 9.
22. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, et al. (1999) Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42: 963-70.
23. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, et al. (2002) Genemicroarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8: 500-8.
24. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
25. Murugaiyan G, Mittal A, Weiner HL (2008) Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol 181: 7480-8.
26. Boon L, Brok HP, Bauer J, Ortiz-Buijsse A, Schellekens MM, et al. (2001) Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J Immunol 167: 2942-9.
27. Hart BA, Hintzen RQ, Laman JD (2008) Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis. Neurodegener Dis 5: 38-52.
28. Buck D, Kroner A, Rieckmann P, Maurer M, Wiendl H (2006) Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosis. Tissue Antigens 68: 335-8.
29. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (2007). Nature 447: 661-78.
30. McGovern DP, Gardet A, Torkvist L, Goyette P, Essers J, et al. (2010) Genomewide association identifies multiple ulcerative colitis susceptibility loci. Nature 42: 332-7. Epub 2010 Mar 14.
31. Zheng J, Liu Y, Qin G, Chan PL, Mao H, et al. (2009) Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naïve precursors by CD40-activated B cells. J Immunol 183: 3742-50;Epub 2009 Aug 14.
32. Zheng J, Liu Y, Lau YL, Tu W (2010) CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells. Cell Mol Immunol 7: 44-50.